申请人:AKZO N.V.
公开号:US05171752A1
公开(公告)日:1992-12-15
The invention relates to a benzhydryl derivative having the formula ##STR1## wherein each of the groups R.sub.1, R.sub.2, and R.sub.3 represents one to four substituents independently selected from the group consisting of hydrogen, lower alkyl, halogen, and CF.sub.3, and at least one of the groups R.sub.1, R.sub.2, and R.sub.3 is halogen or CF.sub.3 ; R.sub.4 represents hydrogen or methyl; n is 2, 3, or 4; m is 1, 2, or 3; and X represents O or S; or its pharmaceutically acceptable salts. The benzhydryl derivative of the invention can be used to treat patients who are suffering from diseases which are influenced by calmodulin.
该发明涉及一种苯基二苄基衍生物,其化学式为##STR1##其中R.sub.1、R.sub.2和R.sub.3各代表从氢、低碳烷基、卤素和CF.sub.3组成的群中独立选择的一个至四个取代基,且R.sub.1、R.sub.2和R.sub.3中至少有一个是卤素或CF.sub.3;R.sub.4代表氢或甲基;n为2、3或4;m为1、2或3;X代表O或S;或其药学上可接受的盐。该发明的苯基二苄基衍生物可用于治疗受钙调蛋白酶影响的疾病患者。